Molecular genetics of schizophrenia

Current Opinion in Psychiatry

Volumn 11, Issue 1, 1998, Pages 19-25

  Maier, Wolfgang ^a   Schwab, Sibylle ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; DOPAMINE 3 RECEPTOR; SEROTONIN 2A RECEPTOR;

CHROMOSOME 13Q; CHROMOSOME 22Q; CHROMOSOME 5Q; CHROMOSOME 6P; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENETIC LINKAGE; GENETIC MARKER; GENOME; HEREDITY; HUMAN; MOLECULAR GENETICS; RECEPTOR GENE; REVIEW; SCHIZOPHRENIA;

EID: 0031975818     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-199801000-00014     Document Type: Review

References (45)

1. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11:241-247.
2. Wildenauer DB, Schwab SG, Eckstein GN, Zill P, Hoenig S, Hallmayer J, et al. Searching for susceptibility genes in schizophrenia by affected sib-pair analysis: evidence for loci in 22q, 5q, 6p. Am J Hum Genet 1995; 57 (Suppl):176.
3. Schwab SG, Eckstein GN, Hallmayer J, Lerer B, Albus M, Borrmann M, et al. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry 1997; 2:156-160. The study describes a suggestive linkage of schizophrenia in two independent samples to chromosome 5q31.
4. Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS. Support for a schizophrenia vulnerability locus in region 5q21 q31 in Irish pedigrees. Mol Psychiatry 1997; 2:148-155. A maximum lod score of 3.3 with markers in 5q21 31 is detected within a relatively homogeneous family sample with schizophrenia. This study also provides a replication of reference 3.
5. Straub RE, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, et al. A potential vulnerability locus for schizophrenia on chromosome 6p24 22: evidence for genetic heterogeneity. Nat Genet 1995; 11:287-293.
6. Schwab SG, Albus M, Hallmayer J, Honig S, Borrmann M, Lichterman D, et al. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat Genet 1995; 11:325-327.
7. Antonarakis SE, Blouin J-L, Pulver AE, Wolyniec P, Lasseter VK, Nestadt G, et al. Schizophrenia susceptibility and chromosome 6p24 22 [Letter]. Nat Genet 1995; 11:235-236.
8. Gurling H, Kalsi G, Chen AH, Green M, Butler R. Read T, et al. Schizophrenia susceptibility and chromosome 6p24 22 [Letter]. Nat Genet 1995; 11:234-235.
9. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F, et al. An International two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet 1995; 11:321-324.
10. Mowry BJ, Sandkuijl LA, Crowe RR, Silverman JM, Mohs RC, Siever LJ, et al. Schizophrenia susceptibility and chromosome 6p24 22 [Letter]. Nat Genet 1995; 11:233-234.
11. Garner C, Kelly M, Cardon L, Joslyn G, Carey A, LeDuc C, et al. Linkage analysis of schizophrenia to chromosome 6p24 p22: an attempt to replicate. Am J Med Genet 1996; 67:595-610.
12. Riley BP, Rajagopalan S, Mogudi-Carter M, Jenkins T, Williamson R. No evidence for linkage of chromosome 6p markers to schizophrenia in Southern African Bantu-speaking families. Psychiatr Genet 1996; 6:41-49.
13. Schizophrenia Linkage Collaborative Group for chromosomes 3, 6 and 8. Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Am J Med Genet 1996; 67:580-594.
14. Arolt V, Lencer R, Nolte A, Mueller-Myhsok B, Purmann S, Schuermann M, et al. Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. Am J Med Genet 1996; 67:654-679.
15. Maziade M, Bissonnette L, Rouillard E, Martinez M, Turgeon M, Charron L, et al. 6p24 22 region and major psychoses in the Eastern Quebec population. Am J Med Genet 1997; 74:311-318.
16. Wildenauer DB, Hallmayer J, Schwab SG, Albus M, Eckstein GN, Zill P, et al. Searching for susceptibility genes in schizophrenia by genetic linkage analysis. In: Cold Spring Harbour Symposia on Quantitative Biology, volume LXI. Cold Spring Harbour: Cold Spring Harbour Laboratory Press; 1996. pp. 845-850. This paper is a review of the results so far obtained by this group.
17. Pulver AE, Lasseter VK, Kasch L, Wolyniec P, Nestadt G, Blouin J-L, et al. Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 1995; 60:252-260.
18. Kendler KS, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, et al. Evidence of a schizophrenia vulnerability locus on chromosome 8p in the Irish study of high-density schizophrenia families. Am J Psychiatry 1996; 153:1534-1540. Detection of a susceptibility locus on chromosome 8p.
19. Pulver AE, Wolyniec PS, Housman D, Kazazian HH, Antonarakis SE, Nestadt G, et al. The Johns Hopkins University collaborative schizophrenia study: an epidemiologic genetic approach to test the heterogeneity hypothesis and identify schizophrenia susceptibility genes. In: Cold Spring Harbour Symposia on Quantitative Biology, volume LXI. Cold Spring Harbour: Cold Spring Harbour Laboratory Press; 1996. pp. 797-814. This paper is a review of the results so far obtained by this group.
20. Lin MW, Curtis D, Williams N, Arranz M, Nanko S, Collier D, et al. Suggestive evidence for linkage of schizophrenia to markers on chromosome 13q14.1 q32. Psychiatr Genet 1995; 5:117-126.
21. Coon H, Holik J, Hoff M, Reimherr F, Wender P, Myles-Worsley M, et al. Analysis of chromosome 22 markers in nine schizophrenia pedigrees. Am J Med Genet 1994; 54:72-79.
22. Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G, et al. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12 q13.1: Part 1. Am J Med Genet 1994; 54:36-43.
23. Schizophrenia Collaborative Linkage Group (Chromosome 22). A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Am J Med Genet 1996; 67:40-45.
24. Clerget-Darpoux F, Bonaiti-Pellié C, Hochez J. Effects of mis-specifying genetic parameters in lod score analysis. Biometrics 1986, 42:393-399.
25. Nöthen MM, Propping P, Fimmers R. Association versus linkage studies in psychosis genetics. J Med Genet 1992; 30:634-637.
26. Crocq M-A, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 1992; 29:858-860.
27. Shaikh S, Collier DA, Sham PC, Ball D, Aitchison K, Vallada H, et al. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Hum Genet 1996; 97:714-719.
28. Griffon N, Crocq MA, Pilon C, Martres MP, Mayerova A, Uyanik G, et al. Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia. Am J Med Genet 1996; 67:63-70.
29. Rothschild LG, Badner J, Cravchik A, Gershon ES, Gejman PV. No association detected between a D3 receptor gene-expressed variant and schizophrenia. Am J Med Genet 1996; 67:232-234.
30. 9 polymorphism and schizophrenia: no increased frequency of homozygosity in German familial cases. Schizophr Res 1996; 20:181-186.
31. 2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet 1996; 97:614-619.
32. Inayama Y, Yoneda H, Sakai T, Ishida T, Nonomusa Y, Kono Y, et al. Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. Am J Med Genet 1996; 67:103-105.
33. Williams J, Spurlock G, McGuffin P, Mallet J, Nöthen MM, Gill M, et al., for the European Multicentre Association Study of Schizophrenia (EMASS) Group: Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. Lancet 1996, 347:1294-1296.
34. 2a receptor T102C polymorphism and schizophrenia [Letter]. Lancet 1996; 347:1830-1831.
35. 2 receptor gene locus: association with schizophrenia or treatment response not detected. Psychiatr Genet 1996; 6:23-27.
36. 2a receptor T102C polymorphism and schizophrenia [Letter]. Lancet 1996; 347:1831.
37. 2a receptor T102C polymorphism and schizophrenia [Letter]. Lancet 1996; 347:1831-1832.
38. 2a receptor T102C polymorphism and schizophrenia [Letter]. Lancet 1996; 347:1832.
39. Verga M, Macciardi F, Cohen S, Pedrini S, Smeraldi E. No association between schizophrenia and the serotonin receptor 5HTR2a in an Italian population. Am J Med Genet 1997; 74:21-25.
40. Hawi Z, Myakishev MV, Sträub RE, O'Neill A, Kendler KS, Walsh D, et al. No association or linkage between the 5HT2A/T102C polymorphism and schizophrenia in Irish families. Am J Med Genet 1997; 74:370-373. First family based association study as well as linkage study with the 5HT2A/T102C polymorphism and schizophrenia.
41. 2 receptor and schizophrenia in a large Swedish kindred. Arch Gen Psychiatry 1992; 49:216-219.
42. Wang C, Jian XD, Zhao XZ. Investigation of allotypes of HLA class III (CZ, BF and C4) in patients with schizophrenia. Chin Med J Engl 1992; 105:316-318.
43. Nimgaonkar VL, Ganguli R, Rudert WA, Vavassori C. A negative association of schizophrenia with an allele of the HLA DQB1 gene among African-Americans. Schizophr Res 1993; 8:199-209.
44. Zamani MG, De Hert M, Spaepen M, Hermans M, Marynen P, Cassiman J-J, et al. Study of the possible association of HLA class II, CD4, and CD3 polymorphisms with schizophrenia. Am J Med Genet 1994; 54:372-377.
45. Ross CA, Pearlson GD. Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach. Trends Neurosci 1996; 19:171-176.